Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic Leukemia

Marcos de Lima; Partow Kebriaei; Francesco Lanza; Christina Cho; Gizelle Popradi; Manmeet Kaur; Mei Jie Zhang; Fan Zhang; Richa Shah; Erik Vandendries; Kofi Asomaning; Stephanie Dorman; Matthias Stelljes; David I. Marks; Wael Saber

doi:10.1002/ajh.27637

Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic Leukemia

Marcos de Lima
, Partow Kebriaei
, Francesco Lanza
, Christina Cho
, Gizelle Popradi
, Manmeet Kaur
, Mei Jie Zhang
, Fan Zhang
, Richa Shah
, Erik Vandendries
, Kofi Asomaning
, Stephanie Dorman
, Matthias Stelljes
, David I. Marks
, Wael Saber

School of Medicine

Ohio State University
University of Texas MD Anderson Cancer Center
University of Bologna
McGill University
Medical College of Wisconsin
Pfizer Inc
Pfizer
University of Münster
University Hospitals Bristol and Weston NHS Foundation Trust

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	909-912
Number of pages	4
Journal	American Journal of Hematology
Volume	100
Issue number	5
DOIs	https://doi.org/10.1002/ajh.27637
State	Published - May 2025

Keywords

ALL
VOD
marrow/stem cell transplantation—clinical results in acute leukemia
stem cell transplantation
veno-occlusive disease

Access to Document

10.1002/ajh.27637

Cite this

de Lima, M., Kebriaei, P., Lanza, F., Cho, C., Popradi, G., Kaur, M., Zhang, M. J., Zhang, F., Shah, R., Vandendries, E., Asomaning, K., Dorman, S., Stelljes, M., Marks, D. I., & Saber, W. (2025). Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic Leukemia. American Journal of Hematology, 100(5), 909-912. https://doi.org/10.1002/ajh.27637

@article{6e6c50255cb148789b57dbff1f3e4b50,

title = "Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic Leukemia",

keywords = "ALL, VOD, marrow/stem cell transplantation{\textemdash}clinical results in acute leukemia, stem cell transplantation, veno-occlusive disease",

author = "\{de Lima\}, Marcos and Partow Kebriaei and Francesco Lanza and Christina Cho and Gizelle Popradi and Manmeet Kaur and Zhang, \{Mei Jie\} and Fan Zhang and Richa Shah and Erik Vandendries and Kofi Asomaning and Stephanie Dorman and Matthias Stelljes and Marks, \{David I.\} and Wael Saber",

year = "2025",

month = may,

doi = "10.1002/ajh.27637",

language = "English",

volume = "100",

pages = "909--912",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "John Wiley and Sons Inc",

number = "5",

}

de Lima, M, Kebriaei, P, Lanza, F, Cho, C, Popradi, G, Kaur, M, Zhang, MJ, Zhang, F, Shah, R, Vandendries, E, Asomaning, K, Dorman, S, Stelljes, M, Marks, DI & Saber, W 2025, 'Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic Leukemia', American Journal of Hematology, vol. 100, no. 5, pp. 909-912. https://doi.org/10.1002/ajh.27637

TY - JOUR

T1 - Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic Leukemia

AU - de Lima, Marcos

AU - Kebriaei, Partow

AU - Lanza, Francesco

AU - Cho, Christina

AU - Popradi, Gizelle

AU - Kaur, Manmeet

AU - Zhang, Mei Jie

AU - Zhang, Fan

AU - Shah, Richa

AU - Vandendries, Erik

AU - Asomaning, Kofi

AU - Dorman, Stephanie

AU - Stelljes, Matthias

AU - Marks, David I.

AU - Saber, Wael

PY - 2025/5

Y1 - 2025/5

KW - ALL

KW - VOD

KW - marrow/stem cell transplantation—clinical results in acute leukemia

KW - stem cell transplantation

KW - veno-occlusive disease

UR - https://www.scopus.com/pages/publications/85218680599

U2 - 10.1002/ajh.27637

DO - 10.1002/ajh.27637

M3 - Letter

C2 - 39989181

AN - SCOPUS:85218680599

SN - 0361-8609

VL - 100

SP - 909

EP - 912

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 5

ER -

Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic Leukemia

Keywords

Access to Document

Other files and links

Cite this